1. Home
  2. REAL vs ALVO Comparison

REAL vs ALVO Comparison

Compare REAL & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The RealReal Inc.

REAL

The RealReal Inc.

HOLD

Current Price

$16.95

Market Cap

1.7B

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$4.84

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REAL
ALVO
Founded
2011
2013
Country
United States
Luxembourg
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
REAL
ALVO
Price
$16.95
$4.84
Analyst Decision
Buy
Buy
Analyst Count
8
4
Target Price
$16.00
$9.25
AVG Volume (30 Days)
2.7M
560.2K
Earning Date
02-19-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.24
Revenue
$662,789,000.00
$573,350,000.00
Revenue This Year
$17.10
$20.85
Revenue Next Year
$10.90
$44.49
P/E Ratio
N/A
$20.53
Revenue Growth
14.30
45.55
52 Week Low
$4.61
$4.32
52 Week High
$16.90
$13.70

Technical Indicators

Market Signals
Indicator
REAL
ALVO
Relative Strength Index (RSI) 69.44 44.75
Support Level $15.67 $4.61
Resistance Level $16.71 $4.96
Average True Range (ATR) 0.75 0.26
MACD 0.01 0.02
Stochastic Oscillator 93.28 46.41

Price Performance

Historical Comparison
REAL
ALVO

About REAL The RealReal Inc.

The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.

About ALVO Alvotech

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.

Share on Social Networks: